The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progression
- 28 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (9), 34C-39C
- https://doi.org/10.1016/s0002-9149(99)80468-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Kuopio Atherosclerosis Prevention Study (KAPS)Circulation, 1995
- Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)The American Journal of Cardiology, 1995
- Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross‐over trial in male smokersJournal of Internal Medicine, 1995
- Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.Circulation, 1994
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)Annals of Internal Medicine, 1993
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992